Genmab — Februar 2017
-
hehe ja okay. Så må du jo lære af knægten Helge
-
Gode tanker fra Darvin om Genmab - niveau og risiko: http://www.proinvestor.com/debat/75444
-
tak for link Helge. Og helt enig i at det er gode tanker om casen Genmab.
-
Den er ved at bygge et fundament her i all time high frem mod salgstal og regnskab med mulige nyheder(tvivler dog). Tallene tror jeg afgør om den vil stige videre eller der kommer et lille tilbage fald fordi tallene måske kan skuffe en lille smule da folk måske ikke er færdige med forrige behandling endnu, dem der er i 2 eller 3 behandling nu.
-
Handlet 40.000 i slutauktionen.
-
ja helt sygt igen igen
-
Næsten 25% af dagens handel.
-
Hi everyone, regarding the closing volumes. I’m not that sure that those trades are being made at the close itself, it just doesn’t make any sense.. A simple thought that came to my mind is that they are derivatives that have been traded during the day and that are added to the volume at the end of the day. Could also be something else, but it just doesn’t make any sense why 10% - 30% of the daily volume is being traded at the close. Any thoughts?
-
i agree
-
Genmab søger medarbejdere. http://uniqueconsult.dk/en/compliance-adviser/
-
Hvis de ikke når det inden onsdag d. 22 så tror jeg du taber. 
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind